Stephen M. Hewitt Bethesda, MD, USA
Stephen M. Hewitt, M.D., Ph.D., is appointed as a Clinical Investigator within the Laboratory of Pathology, Center for Cancer Research, National Cancer Institute at the National Institutes of Health, in Bethesda Maryland. He has served as head of the Experimental Pathology Laboratory, since its inception in 2014, having previously led the Tissue Array Research Program from 2000 to 2014, and the Applied Molecular Pathology Laboratory from 2008 – 2014.
Dr. Hewitt's research interests are in the development of tissue-based biomarkers for cancer diagnosis, prognosis and prediction of response to therapy. Specific areas of concentration include tissue microarrays, biobanking of pathology specimens, tissue proteomics, whole slide imaging /image analysis, and cancers of the aero-digestive and urogenitial tracts.
Stephen received his bachelor's degree in philosophy from the Johns Hopkins University in 1988, and his Ph.D. in genetics from the University of Texas, Graduate School of Biomedical Sciences in 1995, having completed his thesis in the laboratory of Grady Saunders at the University of Texas M.D. Anderson Cancer Center. He completed his M.D. in 1996 at the University of Texas Medical School at Houston, and his residency in Anatomic Pathology within the Laboratory of Pathology at the National Cancer Institute. He is a board certified Anatomic Pathologist and Fellow of the College of American Pathologists and Fellow of the American Society of Clinical Pathology. Dr. Hewitt is chair of the Subcommittee on Immunohistochemical Assays for the Clinical Laboratory Standards Institute. He is Editor-in-Chief of Journal of Histochemistry and Cytochemistry. Dr. Hewitt serves on the council of the Association for Pathology Informatics and is a consultant to the Hematology and Pathology Devices Panel, Center for Devices and Radiological Health, Food and Drug Administration. Dr. Hewitt has co-authored more than 275 articles and serves on the editorial board of four peer-reviewed journals.
